Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PDLIM4 contributors: mct - updated : 19-03-2010
HGNC name PDZ and LIM domain 4
HGNC id 16501
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • two N-terminal cysteine-rich LIM/double zinc finger motifs (LIM domains)
  • a PDZ/DHR domain
  • HOMOLOGY
    interspecies homolog to rattus Ril 1
    ortholog to murine Ril-pending
    Homologene
    FAMILY
  • ALP/Enigma family of PDZ and LIM domain-containing adapter proteins
  • CATEGORY transcription factor , tumor suppressor
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,nucleus
    basic FUNCTION
  • may be involved in intracellular signaling cascade
  • PDZ-LIM protein acting as a regulator of actin stress fiber turnover
  • frequently lost in colon and other cancers as a result of epigenetic silencing, suppresses Src activation
  • may function as a tumor suppressor, involved in the control of cell proliferation by associating with actin in prostate cancer cells
  • implicated in regulation of actin stress fiber turnover
  • CELLULAR PROCESS nucleotide, transcription
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling signal transduction
    intracellular signaling cascade
    a component
    INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • Zn2+
  • protein
  • associated with alpha-actinin via its PDZ domain
  • interacting with PTPN13 and SRC (suppresses SRC activation through interacting with SRC and PTPN13, allowing PTPN13-dependent dephosphorylation of SRC at the activation loop)
  • direct interaction of PDLIM4 with F-actin
  • binds to alpha-actinin, enhances its ability to interact with actin filaments, and promotes formation of actin stress fibers
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    by hypermethylation in renal cell carcinoma
    tumoral     --low  
    by hypermethylation in acute myelogenous leukemia and colon cancer (60 p100 of cases)
    Susceptibility to osteoporosis
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancer  
    good candidate tumor suppressor gene silenced by hypermethylation in cancer
    ANIMAL & CELL MODELS